Overview
- Lilly will own and operate an Nvidia DGX SuperPOD with DGX B300 systems powered by more than 1,000 Blackwell Ultra GPUs.
- The buildout is slated to finish in December 2025, with the supercomputer and AI factory going online in January 2026.
- Researchers plan to train AI models on millions of experiments to broaden and speed testing of potential medicines.
- Through the TuneLab platform, biotechs can access Lilly’s proprietary models via federated learning without exchanging raw data.
- Beyond discovery, Lilly targets shorter development cycles and applications in manufacturing, medical imaging and enterprise AI agents, while forecasting significant returns closer to 2030.